ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells
Yoon Kyung Jo1, So Jung Park, Ji Hyun Shin
1Institute for Innovative Cancer Research, Asan Medical Center, Seoul 138-736, Republic of Korea.
Abstract:
Autophagy is a catabolic cellular process involving self-digestion and turnover of macromolecules and entire organelles. Autophagy is primarily a protective process in response to cellular stress, but it can be associated with cell death. Genetic evidence also supports autophagy function as a tumor suppressor mechanism. To identify specific regulators to autophagy, we screened the Lopac 1280 and the Prestwick chemical libraries using a cell-based screening system with autophagy marker (green fluorescence protein conjugated LC3 protein (GFP-LC3)). We identified ARP101, a selective matrix metalloproteinase-2 (MMP-2) inhibitor as one of the most potent inducer of autophagy. ARP101 treatment was highly effective in inducing the formation of autophagosome and conversion of LC3I into LC3II. Moreover, ARP101-induced autophagy was completely blocked in mouse embryo fibroblasts that lacked autophagy related gene 5 (ATG5(-/-) MEF). Interestingly, cell death induced by ARP101 was not inhibited by zVAD, a pan caspase inhibitor, whereas, it was efficiently suppressed by addition of 3-methyladenine, an autophagy inhibitor. These results suggest that the selective MMP-2 inhibitor, ARP101, induces autophagy and autophagy-associated cell death.
Insights
A selective matrix metalloproteinase-2 (MMP-2) inhibitor, ARP101, potently induces autophagy, a cellular self-digestion process. This autophagy induction by ARP101 is linked to significant cell death, highlighting a novel therapeutic avenue.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Autophagy is a fundamental cellular process for macromolecule and organelle turnover, crucial for cellular stress response.
- While often protective, autophagy can be implicated in cell death pathways and acts as a tumor suppressor mechanism.
- Identifying specific regulators of autophagy is key to understanding its diverse roles.
Purpose of the Study:
- To identify novel chemical regulators that modulate autophagy.
- To investigate the mechanism by which identified compounds induce autophagy.
- To determine the role of autophagy in ARP101-induced cell death.
Main Methods:
- Screening of chemical libraries (Lopac 1280, Prestwick) using a GFP-LC3 autophagy marker system.
- Treatment of cells with ARP101 and assessment of autophagosome formation and LC3 conversion (LC3I to LC3II).
- Utilizing ATG5(-/-) MEF cells to confirm autophagy-dependent effects and employing 3-methyladenine and zVAD to dissect cell death pathways.
Main Results:
- ARP101 was identified as a potent inducer of autophagy, significantly increasing autophagosome formation and LC3II levels.
- ARP101-induced autophagy was dependent on ATG5, confirming its role in the autophagic pathway.
- Cell death induced by ARP101 was mediated by autophagy, as it was blocked by autophagy inhibitors but not by caspase inhibitors.
Conclusions:
- ARP101, a selective MMP-2 inhibitor, is a potent inducer of autophagy.
- The study demonstrates that ARP101-induced cell death is associated with and dependent on autophagy.
- These findings suggest ARP101 as a potential therapeutic agent targeting pathways involving autophagy and cell death.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy


